Trial Profile
A retrospective, multicenter study to investigate the impact of concomitant corticosteroid and Vedolizumab treatment in patients with inflammatory bowel disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2018
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary) ; Corticosteroid
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
- 01 Nov 2017 Results assessing treatment persistence presented at the 25th United European Gastroenterology Week
- 24 May 2017 Results presented at the 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
- 24 May 2017 New trial record